These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18981889)

  • 41. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.
    Low JS; Tao Q; Ng KM; Goh HK; Shu XS; Woo WL; Ambinder RF; Srivastava G; Shamay M; Chan AT; Popescu NC; Hsieh WS
    Oncogene; 2011 Apr; 30(16):1923-35. PubMed ID: 21217778
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The intracellular stability of DLC1 is regulated by the 26S proteasome in human hepatocellular carcinoma cell line Hep3B.
    Luo HW; Luo QP; Yuan Y; Zhu XY; Huang SF; Peng Z; Li CL; Huang ZG; Feng WL
    Biochem Biophys Res Commun; 2011 Jan; 404(1):279-83. PubMed ID: 21130076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
    Ullmannova V; Popescu NC
    Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
    Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
    Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression.
    Schulten HJ; Hussein D; Al-Adwani F; Karim S; Al-Maghrabi J; Al-Sharif M; Jamal A; Al-Ghamdi F; Baeesa SS; Bangash M; Chaudhary A; Al-Qahtani M
    PLoS One; 2016; 11(4):e0153681. PubMed ID: 27096627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas.
    Aarhus M; Bruland O; Bredholt G; Lybaek H; Husebye ES; Krossnes BK; Vedeler C; Wester K; Lund-Johansen M; Knappskog PM
    J Neurooncol; 2008 Jul; 88(3):251-9. PubMed ID: 18365142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas.
    Fürtjes G; Köchling M; Peetz-Dienhart S; Wagner A; Heß K; Hasselblatt M; Senner V; Stummer W; Paulus W; Brokinkel B
    J Neurooncol; 2016 Oct; 130(1):79-87. PubMed ID: 27465278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
    Guan M; Tripathi V; Zhou X; Popescu NC
    Cancer Gene Ther; 2008 Jun; 15(6):371-81. PubMed ID: 18369381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
    Ullmannova-Benson V; Guan M; Zhou X; Tripathi V; Yang XY; Zimonjic DB; Popescu NC
    Leukemia; 2009 Feb; 23(2):383-90. PubMed ID: 18923442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Akt phosphorylation of deleted in liver cancer 1 abrogates its suppression of liver cancer tumorigenesis and metastasis.
    Ko FC; Chan LK; Tung EK; Lowe SW; Ng IO; Yam JW
    Gastroenterology; 2010 Oct; 139(4):1397-407. PubMed ID: 20600027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
    Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
    Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of DLC1 gene methylation with oncogenic PIK3CA mutations in extramammary Paget's disease.
    Kang Z; Xu F; Zhang QA; Lin J; Wu Z; Zhang X; Luo Y; Xu J; Guan M
    Mod Pathol; 2012 Aug; 25(8):1160-8. PubMed ID: 22522847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced expression of ELAVL4 in male meningioma patients.
    Stawski R; Piaskowski S; Stoczynska-Fidelus E; Wozniak K; Bienkowski M; Zakrzewska M; Witusik-Perkowska M; Jaskolski DJ; Och W; Papierz W; Sikorska B; Rieske P; Liberski PP
    Brain Tumor Pathol; 2013 Jul; 30(3):160-6. PubMed ID: 22965691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The SAM domain of the RhoGAP DLC1 binds EF1A1 to regulate cell migration.
    Zhong D; Zhang J; Yang S; Soh UJ; Buschdorf JP; Zhou YT; Yang D; Low BC
    J Cell Sci; 2009 Feb; 122(Pt 3):414-24. PubMed ID: 19158340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role and regulatory mechanism of IL-1β on the methylation of the NF2 gene in benign meningiomas and leptomeninges.
    Wang B; Cui Z; Zhong Z; Sun Y; Yang GY; Sun Q; Bian L
    Mol Carcinog; 2016 Dec; 55(12):2268-2277. PubMed ID: 26840621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression.
    Yam JW; Ko FC; Chan CY; Jin DY; Ng IO
    Cancer Res; 2006 Sep; 66(17):8367-72. PubMed ID: 16951145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
    Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
    J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
    Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF
    Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.
    Sabbir MG; Prieditis H; Ravinsky E; Mowat MR
    PLoS One; 2012; 7(7):e40302. PubMed ID: 22792269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.